Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Brief Report: Pain and Post-Traumatic Stress Disorder Screening Outcomes Among Military Personnel Injured During Combat Deployment.

Image of 03_Pain and PTSD. U.S. Air Force Airman 1st Class Miranda Lugo, right, 18th Operational Medical Readiness Squadron mental health technician and Guardian Wingman trainer, and Maj. Joanna Ho, left, 18th OMRS director of psychological health, discuss the suicide prevention training program, Guardian Wingman, at Kadena Air Base, Japan, Aug. 20, 2021. Guardian Wingman aims to promote wingman culture and early help-seeking behavior. (U.S. Air Force photo by Airman 1st Class Anna Nolte)

Background

The post-9/11 U.S. military conflicts in Iraq and Afghanistan lasted over a decade and yielded the most combat casualties since the Vietnam War.1 While patient survivability increased to the high­est level in history, a changing epidemiology of combat injuries emerged whereby focus shifted to addressing an array of long-term sequelae, including physical, psychologi­cal, and neurological issues.2,3 The long-term effects of combat injury can adversely impact well-being and exact a significant burden on the health care system.4–6
Physical pain is common among mili­tary personnel returning from deployment, particularly those injured in combat,7–9 and is associated with detrimental effects such as medical discharge10 and sub­stance use disorders.11 Pain has also been linked to post-traumatic stress disorder (PTSD), which is common in veterans of the Iraq and Afghanistan conflicts.12 The mutual maintenance model posits that PTSD symptoms may exacerbate chronic pain and, in turn, pain may contribute to or enhance existing PTSD symptoms.13 PTSD is associated with negative outcomes among veterans with chronic pain, includ­ing disability, decreased functioning, and sleep disturbances,14 making the study of pain and PTSD essential for improved patient care and rehabilitation. 
Previous research on the co-occur­rence of pain and PTSD in wounded ser­vice members has been limited by small sample sizes, specific injuries, or short follow-up periods.15–17 The present study adds to the existing literature by examin­ing the association between pain and PTSD screening outcomes nearly a decade after combat injury among a large, national sam­ple of service members and veterans who were injured during deployment and expe­rienced a wide range of injuries.

Methods

Data were collected from the Wounded Warrior Recovery Project (WWRP).4 Par­ticipants are identified from the Expedition­ary Medical Encounter Database (EMED), a deployment health repository maintained by the Naval Health Research Center that includes clinical records of service mem­bers injured in overseas contingency oper­ations since 2001.18 Individuals whose data are in the EMED are approached via postal mail and email to provide informed con­sent for participation in the WWRP and to complete biannual assessments of patient-reported outcomes for 15 years. Enrollment is conducted on a rolling basis, and data collection is ongoing. 

The present study utilized cross-sec­tional data from the seventh wave of the WWRP (i.e., 36 months post-baseline survey), when participants were asked to report on their pain during the past 6 months using the Chronic Pain Grading Scale.19 The measure was introduced into the WWRP in 2015 and was asked of all participants only at the seventh wave. Stan­dardized scoring procedures were used to calculate (1) pain intensity (a composite variable derived from current pain, worst pain in the past 6 months, and average pain in the past 6 months), (2) frequency of pain interference (number of days in the past 6 months that the respondent has been kept from their usual activities such as work, school, or housework because of pain), and (3) level of pain interference (a composite variable of how much pain has interfered with daily activities; recreational, social, and family activities; and ability to work, including housework).
PTSD screening status was measured using the PTSD Checklist–Civilian ver­sion (PCL-C) and PTSD Checklist for the DSM-5 (PCL-5). Both versions of the PCL are comparable in military personnel and veterans.20 WWRP measures and proce­dures were updated in late 2018 to remain consistent with current standards of mea­surement of PTSD symptoms. Scores were summed for each PCL-related measure. Standard cutoffs of 44 and 33 indicated positive screens for PTSD using the PCL-C and PCL-5, respectively.21,22 

Data from 2,649 combat-injured ser­vice members and veterans who partici­pated in the WWRP between 1 December 2015 and 30 September 2021 were included in the analysis. Injury date, Injury Sever­ity Scores (ISS), and demographics were obtained from the EMED. The ISS is a scor­ing system that accounts for multiple inju­ries in a patient and provides an overall measure of injury severity that ranges from 0 (no injury) to 75 (fatal injury). ISS was categorized as mild (1–3), moderate (4–8), and serious/severe (ISS 9+). Indepen­dent sample t-tests were used to examine mean differences in pain variables by PTSD screening status. An alpha level of .05 was considered statistically significant. Analy­ses were performed using SPSS Statistics, version 25 (IBM Corp., Armonk, NY).

Results

Participants were mostly enlisted, non-Hispanic White males in the Army (Table). At the time of the WWRP assess­ment, mean age was 37.2 years (standard deviation [SD]=7.6) and average time since injury was 9.4 years (SD=3.7). A majority of participants (86.9%) were injured in a blast and over one-half (54.1%) sustained mild injuries overall. Injury severity was not associated with PTSD screening sta­tus (p=.212). Participants who screened positive for PTSD had higher average pain intensity (60.6 vs. 37.5, p<.001, d=1.10), days of pain interference (42.7 vs. 9.8, p<.001, d=0.80), and level of pain interfer­ence (50.7 vs. 20.3, p<.001, d=1.29) than those who screened negative.

Editorial Comment

This study describes a significant association between PTSD screening out­comes and pain following combat injury. These results are consistent with previous literature and reaffirm that psychological and physical health issues can overlap and potentially complicate patient manage­ment.3 In a report by Shipherd et al.,23 66% of veterans who sought treatment for PTSD had comorbid chronic pain. Another study found that diagnosis of PTSD yielded 5 times greater odds of persistent pain com­plaints,24 and other research suggests a link between greater pain severity after combat injury and PTSD risk.25 Further, the poly­trauma clinical triad (co-occurrence of concussion, pain, and PTSD) was found in 42% of military polytrauma patients.8 Sharp and Harvey13 highlighted several possible pathways whereby pain and PTSD could be mutually maintaining, including pain acting as a reminder of the trauma, reduced activity levels, and increased pain perception due to elevated anxiety. Nota­bly, injury severity in the present study was not associated with PTSD screening sta­tus. This finding is consistent with previ­ous research17 and can be explained by ISS being a measure of mortality risk, which may not be directly related to other out­comes, such as mental health. Future stud­ies are needed to elucidate the etiological pathways of comorbid pain and PTSD after combat injury. Because pain and PTSD can co-occur many years after injury, the early recog­nition and identification of these condi­tions in primary care settings and through periodical health assessments may be important to refine clinical practice and, ultimately, improve the overall public health of the military.

Furthermore, the use of multidisciplinary health care teams should be examined and considered for use in future military conflicts to address co-occurring physical and psychological issues, which negatively impact long-term quality of life.3 A similar model was suc­cessfully employed to increase return-to-duty rates following concussion and could be adapted to address other injuries.26 Such interventions should be considered for veterans in long-term care and also during the early phase following combat injury, as recent research demonstrated that symptom complaints in the initial year post-injury predicted mental and physical health years later.27 

This analysis has several limitations that should be considered when interpret­ing the results. A key limitation is due to the cross-sectional design of this study; because PTSD and pain were measured at a single point in time, their temporal­ity could not be assessed. Elucidating this relationship could be useful in developing targeted intervention and treatment strat­egies. Further, measures were obtained on average 9 years after injury, and other factors unaccounted for in the present study (e.g., depression, sleep problems, concussion) may influence the relation­ship between pain and PTSD. Additional research is needed to examine this relation­ship over time and include an assessment of confounders. Nevertheless, the findings suggest that pain is associated with PTSD years after injury and could inform medi­cal providers involved in the treatment and rehabilitation of military personnel after combat injury.

Author Affiliations

Naval Health Research Center, San Diego, CA (Dr. Mac­Gregor, Dr. Jurick, Dr. McCabe, Dr. Harb­ertson, Ms. Dougherty, and Mr. Galarneau); Leidos, Inc., San Diego, CA (Dr. Jurick, Dr. McCabe, Dr. Harbertson, Ms. Dougherty); Axiom Resource Management, Inc., San Diego, CA (Dr. MacGregor).

Disclaimer

The authors are military service members or employees of the U.S. Government. This work was prepared as part of their official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that per­son’s official duties. Report No. 22-19 was supported by the U.S. Navy Bureau of Medi­cine and Surgery under work unit no. 60808. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Depart­ment of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in com­pliance with all applicable Federal regula­tions governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center Institutional Review Board protocol, number NHRC.2009.0014.

References

  1. Goldberg MS. Casualty rates of US military personnel during the wars in Iraq and Afghanistan. Defence Peace Econ. 2018;29(1):44–61.
  2. Cannon JW, Holena DN, Geng Z, et al. Com­prehensive analysis of combat casualty outcomes in U.S. service members from the beginning of World War II to the end of Operation Enduring Free­dom. J Trauma Acute Care Surg. 2020;89(suppl 2):S8–S15.
  3. MacGregor AJ, Zouris JM, Watrous JR, et al. Multimorbidity and quality of life after blast-relat­ed injury among US military personnel: a cluster analysis of retrospective data. BMC Public Health. 2020;20(1):578.
  4. Watrous JR, Dougherty AL, McCabe CT, Sack DI, Galarneau MR. The Wounded Warrior Recov­ery Project: a longitudinal examination of patient-reported outcomes among deployment-injured military personnel. Mil Med. 2019;184(3-4):84–89.
  5. Dalton MK, Jarman MP, Manful A, Koehlmoos TP, Cooper Z, Weissman JS, Schoenfeld AJ. The hidden costs of war: healthcare utilization among individuals sustaining combat-related trauma (2007–2018). Ann Surg. Published online ahead of print (2 March 2021). 
  6. Geiling J, Rosen JM, Edwards RD. Medical costs of war in 2035: long-term care challenges for veterans of Iraq and Afghanistan. Mil Med. 2012;177(11):1235–1244.
  7. Wilkie R. Fighting pain and addiction for veter­ans. October 26, 2018. https://trumpwhitehouse.archives.gov/articles/fighting-pain-addiction-veter­
    ans/. Accessed March 4, 2022.  
  8. Lew HL, Otis JD, Tun C, Kerns RD, Clark ME, Cifu DX. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clini­cal triad. J Rehabil Res Dev. 2009;46(6):697-702.
  9. Mazzone B, Farrokhi S, Hendershot BD, Mc­Cabe CT, Watrous JR. Prevalence of low back pain and relationship to mental health symptoms and quality of life after a deployment-related lower limb amputation. Spine. 2020;45(19):1368–1375.
  10. Benedict TM, Singleton MD, Nitz AJ, Shing TL, Kardouni JR. Effect of chronic low back pain and post-traumatic stress disorder on the risk for separation from the US Army. Mil Med. 2019;184(9-10):431–439.
  11. Dembek ZF, Chekol T, Wu A. The opioid epi­demic: challenge to military medicine and national security. Mil Med. 2020;185(5-6):e662–e667.
  12. Peterson AL. General perspective on the U.S. military conflicts in Iraq and Afghanistan after 20 years. Mil Med. 2021.
  13. Sharp TJ, Harvey AG. Chronic pain and post­traumatic stress disorder: mutual maintenance? Clin Psychol Rev. 2001;21(6):857–877.
  14. Benedict TM, Keenan PG, Nitz AJ, Moeller-Bertram T. Post-traumatic stress disorder symp­toms contribute to worse pain and health outcomes in veterans with PTSD compared to those without: a systematic review with meta-analysis. Mil Med. 2020;185(9-10):e1481–e1491.
  15. Giordano NA, Richmond TS, Farrar JT, Buck­enmaier III CC, Gallagher RM, Polomano RC. Dif­ferential pain presentations observed across post-traumatic stress disorder symptom trajectories after combat injury. Pain Med. 2021;22(11):2638–2647.
  16. Castillo R, Carlini AR, Doukas WC, et al. Ex­tremity trauma among United State military serving in Iraq and Afghanistan: Results from the Military Extremity Trauma and Amputation/Limb Salvage Study. J Ortho Trauma. 2021;35(3)e96–e102.
  17. Soumoff AA, Clark NG, Spinks EA, et al. So­matic symptom severity, not injury severity predicts probable posttraumatic stress disorder and major depressive disorder in wounded service members. J Trauma Stress. 2021;35(1):210–221.
  18. Galarneau MR, Hancock WC, Konoske P, et al. The Navy-Marine Corps Combat Trauma Registry. Mil Med. 2006;171(8):691–697.
  19. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133–149.
  20. LeardMann CA, McMaster HS, Warner S, et al. Comparison of posttraumatic stress disorder checklist instruments from Diagnostic and Sta­tistical Manual of Mental Disorders, fourth edition vs fifth edition in a large cohort of US military ser­vice members and veterans. JAMA Netw Open. 2021;4(4):e218072.
  21. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008;358(5):453–463.
  22. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498.
  23. Shipherd JC, Keyes M, Jovanovic T, et al. Vet­erans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Re­habil Res Dev. 2007;44(2):153–166.
  24. Higgins DM, Kerns RD, Brandt CA, et al. Persistent pain and comorbidity among Op­eration Enduring Freedom/Operation Iraqi Free­dom/Operation New Dawn veterans. Pain Med. 2014;15(5):782–790.
  25. Giordano NA, Bader C, Richmond TS, Polo­mano RC. Complexity of the relationships of pain, posttraumatic stress, and depression in combat-injured populations: an integrative review to inform evidence-based practice. Worldviews Evid Based Nurs. 2018;15(2):113–126.
  26. Spooner SP, Tyner SD, Sowers C, Tsao J, Stuessi K. Utility of a sports medicine model in mili­tary combat concussion and musculoskeletal res­toration care. Mil Med. 2014;179(11):1319–1324.
  27. MacGregor AJ, Dougherty AL, D’Souza EW, et al. Symptom profiles following combat injury and long-term quality of life: a latent class analysis. Qual Life Res. 2021;30(9):2531–2540.

Characteristics of the study population and pain items by post-traumatic stress disorder (PTSD) screening status

You also may be interested in...

In-Theater Mental Health Disorders Among U.S. Soldiers Deployed Between 2008 and 2013

Article
11/1/2022
3

Mental health is a significant concern within the U.S. military, and service members are at substantial risk for developing an array of mental health conditions including anxiety, depression, stress/adjustment issues, and sleep-related disorders.

Update: Contraception Among Active Component Service Women, U.S. Armed Forces, 2017–2021

Article
10/1/2022
2

This report summarizes the annual prevalence of permanent sterilization, as well as use of long- and short-acting reversible contraceptives (LARCs and SARCs, respectively), contraceptive counseling services, and use of emergency contraceptives from 2017 through 2021 among active component U.S. service women.

Surveillance Snapshot: Influenza Immunization Among U.S. Armed Forces Healthcare Workers, August 2017–April 2022

Article
10/1/2022
3

Immunization Among U.S. Armed Forces Healthcare Workers

Viral hepatitis C, active component, U.S. Armed Forces, 2011–2020

Article
10/1/2022
1

This study reports updated numbers and incidence rates of hepatitis C virus (HCV) infection among active component members of the U.S. military using a revised case definition during a 10-year surveillance period between 2011 and 2020.

Update: Routine Screening for Antibodies to Human Immunodeficiency Virus, U.S. Armed Forces, Active and Reserve Components, January 2017–June 2022

Article
9/1/2022
Cover 1

This report provides an update through June 2022 of routine screening results for antibodies to the human immunodeficiency virus (HIV) among members of the active and reserve components of the U.S. Armed Forces. During the full 5 and 1/2-year surveillance period, the HIV seropositivity rates for active component service members were 0.21 positives per 1,000 members of the Army, 0.24 for the Navy, 0.16 for the Marine Corps, and 0.14 for the Air Force.

Letter to the Editor: Clarification of Hepatitis C Virus Screening with Case Definitions and Prevalence Among Trainees

Article
9/1/2022
Cover 3

We read with interest the brief report regarding the prevalence of Hepatitis C Virus (HCV) infection in basic military trainee blood donors by Kasper and colleagues in the November 2021 issue of the Medical Surveillance Monthly Report (MSMR),1 an update of a previous similar report

Evaluation of the MSMR Surveillance Case Definition for Incident Cases of Hepatitis C

Article
9/1/2022
Cover 2

The validity of military hepatitis C virus (HCV) surveillance data is uncertain due to the potential for misclassification introduced when using administrative databases for surveillance purposes. The objectives of this study were to assess the validity of the surveillance case definition used by the Medical Surveillance Monthly Report (MSMR) for HCV, the over and underestimation of cases from surveillance data, and the true burden of HCV disease in the U.S. military.

Brief Report: Menstrual Suppression Among U.S. Female Service Members in the Millennium Cohort Study

Article
9/1/2022
Cover 4

Menstrual suppression allows for the control or complete suppression of menstrual periods through hormonal contraceptive methods. In addition to preventing pregnancy, suppression can alleviate medical conditions and symptoms associated with menstruation such as iron deficiency anemia,1 eliminate logistical hygiene-related challenges, and improve quality of life.

Musculoskeletal Injuries During U.S. Air Force Special Warfare Training Assessment and Selection, Fiscal Years 2019–2021.

Article
8/1/2022
01_Musculoskeletal Injuries

Musculoskeletal (MSK) injuries are costly and the leading cause of medical visits and disability in the U.S. military.1,2 Within training envi­ronments, MSK injuries may lead to a loss of training, deferment to a future class, or voluntary disenrollment from a training pipeline, all of which are impediments to maintaining full levels of manpower and resources for the Department of Defense.

Prevalence and Distribution of Refractive Errors Among Members of the U.S. Armed Forces and the U.S. Coast Guard, 2019.

Article
8/1/2022
02_Refractive Errors

During calendar year 2019, the estimated prevalence of myopia, hyperopia, and astigmatism were 17.5%, 2.1%, and 11.2% in the active component of the U.S. Armed Forces and 10.1%, 1.2%, and 6.1% of the U.S. Coast Guard, respectively.

Surveillance Trends for SARS-CoV-2 and Other Respiratory Pathogens Among U.S. Military Health System Beneficiaries, 27 September 2020–2 October 2021.

Article
7/1/2022
1_COVID-19 testing beneficiaries

Respiratory pathogens, such as influenza and adenovirus, have been the main focus of the Department of Defense Global Respiratory Pathogen Surveillance Program (DoDGRPSP) since 1976.1. However, DoDGRPSP also began focusing on SARS-CoV-2 when COVID-19 was declared a pandemic illness in early March 2020.2. Following this declaration, the DOD quickly adapted and organized its respiratory surveillance program, housed at the U.S. Air Force School of Aerospace Medicine (USAFSAM), in response to this emergent virus.

Suicide Behavior Among Heterosexual, Lesbian/Gay, and Bisexual Active Component Service Members in the U.S. Armed Forces.

Article
7/1/2022
3_Access to care_suicide 2021

Lesbian, gay, and bisexual (LGB) individuals are at a particularly high risk for suicidal behavior in the general population of the United States. This study aims to determine if there are differences in the frequency of lifetime suicide ideation and suicide attempts between heterosexual, lesbian/gay, and bisexual service members in the active component of the U.S. Armed Forces. Self-reported data from the 2015 Department of Defense Health-Related Behaviors Survey were used in the analysis.

Establishment of SARS-CoV-2 Genomic Surveillance Within the Military Health System During 1 March–31 December 2020.

Article
7/1/2022
2_COVID19 genomics_725

This report describes SARS-CoV-2 genomic surveillance conducted by the Department of Defense (DOD) Global Emerging Infections Surveillance Branch and the Next-Generation Sequencing and Bioinformatics Consortium (NGSBC) in response to the COVID-19 pandemic. Samples and sequence data were from SARS-CoV-2 infections occurring among Military Health System (MHS) beneficiaries from 1 March to 31 December 2020.

Brief Report: Phase I Results Using the Virtual Pooled Registry Cancer Linkage System (VPR-CLS) for Military Cancer Surveillance.

Article
7/1/2022
4_lung cancer screening

The Armed Forces Health Surveillance Division, as part of its surveillance mission, periodically conducts studies of cancer incidence among U.S. military service members. However, service members are likely lost to follow-up from the Department of Defense cancer registry and Military Health System data sets after leaving service and during periods of time not on active duty.

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2021

Article
6/1/2022
5_deployed morbidity

As in previous years, among service members deployed during 2021, injury/poisoning, musculoskeletal diseases and signs/symptoms accounted for more than half of the total health care burden during deployment. Compared to garrison disease burden, deployed service members had relatively higher proportions of encounters for respiratory infections, skin diseases, and infectious and parasitic diseases. The recent marked increase in the percentage of total medical encounters attributable to the ICD diagnostic category "other" (23.0% in 2017 to 44.4% in 2021) is likely due to increases in diagnostic testing and immunization associated with the response to the COVID-19 pandemic.

Page 2 of 14 , showing items 16 - 30
First < 1 2 3 4 5  ... > Last 
Refine your search
Last Updated: November 01, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery